TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
3.220
-0.040 (-1.23%)
At close: May 26, 2026, 4:00 PM EDT
3.160
-0.060 (-1.86%)
After-hours: May 26, 2026, 7:47 PM EDT
TriSalus Life Sciences Employees
TriSalus Life Sciences had 102 employees as of December 31, 2025. The number of employees decreased by 8 or -7.27% compared to the previous year.
Employees
102
Change (1Y)
-8
Growth (1Y)
-7.27%
Revenue / Employee
$440,029
Profits / Employee
-$559,451
Market Cap
197.76M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 102 | -8 | -7.27% |
| Dec 31, 2024 | 110 | -2 | -1.79% |
| Dec 31, 2023 | 112 | 37 | 49.33% |
| Dec 31, 2022 | 75 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Inogen | 753 |
| InfuSystem Holdings | 473 |
| RxSight | 461 |
| Treace Medical Concepts | 450 |
| CVRx, Inc. | 223 |
| Apyx Medical | 205 |
| Profound Medical | 162 |
| Quantum-Si incorporated | 145 |
TLSI News
- 13 days ago - TriSalus Life Sciences price target lowered to $8 from $10 at Lake Street - TheFly
- 14 days ago - TriSalus Life Sciences Q1 Earnings Call Highlights - MarketBeat
- 14 days ago - TriSalus Life Sciences reports Q EPS 3c, one estimate (16c) - TheFly
- 14 days ago - TriSalus Life Sciences Earnings Call Transcript: Q1 2026 - Transcripts
- 14 days ago - TriSalus Life Sciences Earnings release: Q1 2026 - Filings
- 14 days ago - TriSalus Life Sciences Quarterly report: Q1 2026 - Filings
- 14 days ago - TriSalus Life Sciences Reports First Quarter 2026 Results Demonstrating Commercial and Clinical Progress for Facilitating Long-Term Growth - Business Wire
- 14 days ago - TriSalus announces journal publication of PEDD study - TheFly